Biorepository for individuals who had COVID-19
Post COVID-19 Biorepository
This study is collecting blood samples and health information from people who have had COVID-19 to help with future research.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center Academic / other |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT04885504 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a biorepository, clinical data registry, and radiographic image database for individuals who have previously tested positive for COVID-19. Participants will provide informed consent and contribute biospecimens, including serum, plasma, and whole blood, during outpatient follow-up visits. Samples will be collected at the time of consent and at follow-up intervals of 3, 6, 12, and 24 months. The collected biospecimens will be processed, stored, and may be used for future research, including whole genome testing.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have a confirmed diagnosis of COVID-19 and are receiving outpatient follow-up care.
Not a fit: Patients who decline to participate or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this biorepository could enhance understanding of long-term effects of COVID-19 and inform future treatments.
How similar studies have performed: Other studies have successfully established biorepositories for infectious diseases, suggesting this approach is viable and beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP). 2. The participant has a previous diagnosis of COVID-19 confirmed by COVID-19 PCR or antibody testing and is being seen for outpatient follow-up. 3. Patient is ≥ 18 years of age or older. Exclusion Criteria: 1. Participant declines to participate. 2. Participant or healthcare surrogate is unable to provide informed consent.
Where this trial is running
Kansas City, Kansas
- University of Kansas Medical Center — Kansas City, Kansas, United States (Recruiting)
Study contacts
- Principal investigator: Leslie A Spikes, MD — University of Kansas Medical Center
- Study coordinator: Adam M Ruff, BS
- Email: aruff@kumc.edu
- Phone: 9135743932
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.